IS BRISTOL-MYERS SQUIBB (BMY) ONE OF THE BEST HEALTHCARE STOCKS TO BUY ACCORDING TO BILLIONAIRES?
https://s.yimg.com/ny/api/res/1.2/ZsrqNB_sdV78LPtS9DZ12A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036
✍️ Bristol-Myers Squibb Company (NYSE:BMY) is a biopharmaceutical company that has experienced strong double-digit revenue growth in 2024, driven by several key products. Despite challenges in the healthcare sector, the company has a solid financial position and has been prioritizing operational efficiency and financial discipline.
👉 Bristol-Myers Squibb Company (NYSE:BMY) is a biopharmaceutical company that has experienced strong double-digit revenue growth in 2024. 👉 The company's portfolio has been driven by products such as BREYANZI, Krazati, Reblozyl, and Opdivo. 👉 The company has a solid financial position, with around $11.2 billion in cash equivalents and marketable securities as of December 31. 👉 The company has been prioritizing operational efficiency and financial discipline, redirecting resources to high-growth opportunities and achieving most of its targeted $1.5 billion in savings.
-- #RobHaworth #CarlCook #RondaStryker #Princeton,NewJersey #healthcare
Loading quoted post…
